Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-25-000405
Filing Date
2025-04-22
Accepted
2025-04-22 07:32:45
Documents
3
Period of Report
2025-04-22

Document Format Files

Seq Description Document Type Size
1 FORM 6-K sndl6k.htm 6-K 12083
2 NEWS RELEASE DATED APRIL 22, 2025 ex991.htm EX-99.1 7550
3 GRAPHIC logo.jpg GRAPHIC 4781
  Complete submission text file 0001279569-25-000405.txt   27495
Mailing Address 919 11 AVENUE SW SUITE 300 CALGARY A0 T2R1P3
Business Address 919 11 AVENUE SW SUITE 300 CALGARY A0 T2R1P3 14039485227
SNDL Inc. (Filer) CIK: 0001766600 (see all company filings)

EIN.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39005 | Film No.: 25854973
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)